| Code | 5848E | ||||||||||
| MA number | 16/0062/24-S | ||||||||||
| Product Form: | tbl flm 14x90 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Swyssi AG, Germany | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 12.04.2024 |
| Validity: | 12.04.2029 |
| SPC: |
SPC_Ticagrelor Swyssi 90 mg_03.2024.pdf
|
| PIL: |
PIL_Ticagrelor Swyssi 90 mg_03.2024.pdf
|
| Dokument: |
VHS_Ticagrelor Swyssi_PAR _04.2024.pdf
|
| Dokument: |
VHS_Ticagrelor Swyssi_PAR summary_04.2024.pdf
|
| Safety feature | Yes |
| Data update: | 16.04.2024 |
